{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:02:00Z","timestamp":1779958920771,"version":"3.53.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jpet.2026.104327","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:50:37Z","timestamp":1775145037000},"page":"104327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological inhibition of both DGK\u03b1 and DGK\u03b6 is required for optimal T cell activation"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5084-5701","authenticated-orcid":false,"given":"Hannah E.","family":"Meibers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle L.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1936-642X","authenticated-orcid":false,"given":"Casey G.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Zepeda-Carranza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Piovesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor E.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3772-2317","authenticated-orcid":false,"given":"Monika","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas R.","family":"Paladugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Nareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Meleza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jose","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Ian P.","family":"Malgapo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8002-5141","authenticated-orcid":false,"given":"Yihong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5050-3891","authenticated-orcid":false,"given":"Kelsey E.","family":"Sivick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9848-9278","authenticated-orcid":false,"given":"Patrick G.","family":"Schweickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jpet.2026.104327_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41573-021-00345-8","article-title":"The foundations of immune checkpoint blockade and the ipilimumab approval decennial","volume":"21","author":"Korman","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"6382","key":"10.1016\/j.jpet.2026.104327_bib2","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jpet.2026.104327_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40364-020-00212-5","article-title":"Resistance to PD-1\/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives","volume":"8","author":"Sun","year":"2020","journal-title":"Biomark Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.104327_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol Cancer"},{"issue":"11","key":"10.1016\/j.jpet.2026.104327_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41573-022-00538-9","article-title":"The expanding role for small molecules in immuno-oncology","volume":"21","author":"Offringa","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.jpet.2026.104327_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s11658-025-00805-8","article-title":"DGKs in lipid signaling and disease intervention: structural basis, pathological mechanisms, and emerging therapeutic strategies","volume":"30","author":"Liu","year":"2025","journal-title":"Cell Mol Biol Lett"},{"issue":"3","key":"10.1016\/j.jpet.2026.104327_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.immuni.2018.08.017","article-title":"PIP5 Kinases Regulate Membrane Phosphoinositide and Actin Composition for Targeted Granule Secretion by Cytotoxic Lymphocytes","volume":"49","author":"Gawden-Bone","year":"2018","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jpet.2026.104327_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/79766","article-title":"RasGRP is essential for mouse thymocyte differentiation and TCR signaling","volume":"1","author":"Dower","year":"2000","journal-title":"Nature Immunology"},{"issue":"2","key":"10.1016\/j.jpet.2026.104327_bib9","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/ijms24021652","article-title":"A Focused Review of Ras Guanine Nucleotide-Releasing Protein 1 in Immune Cells and Cancer","volume":"24","author":"Hsu","year":"2023","journal-title":"Int. J. Mol. Sci"},{"issue":"11","key":"10.1016\/j.jpet.2026.104327_bib10","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1128\/MCB.25.11.4426-4441.2005","article-title":"A Diacylglycerol-Protein Kinase C-RasGRP1 Pathway Directs Ras Activation upon Antigen Receptor Stimulation of T Cells","volume":"25","author":"Roose","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.jpet.2026.104327_bib11","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3390\/cells9112470","article-title":"The Multifaceted Output of c-Jun Biological Activity: Focus at the Junction of CD8 T Cell Activation and Exhaustion","volume":"9","author":"Papavassiliou","year":"2020","journal-title":"Cells"},{"issue":"374","key":"10.1016\/j.jpet.2026.104327_bib12","doi-asserted-by":"crossref","first-page":"re6","DOI":"10.1126\/scisignal.aaa0974","article-title":"Redundant and specialized roles for diacylglycerol kinases \u03b1 and \u03b6 in the control of T cell functions","volume":"8","author":"M\u00e9rida","year":"2015","journal-title":"Sci Signal"},{"issue":"22","key":"10.1016\/j.jpet.2026.104327_bib13","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1091\/mbc.e11-03-0247","article-title":"Diacylglycerol kinase \u03b6 controls diacylglycerol metabolism at the immunological synapse","volume":"22","author":"Gharbi","year":"2011","journal-title":"Mol Biol Cell"},{"issue":"303","key":"10.1016\/j.jpet.2026.104327_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004373","article-title":"The \u03b6 isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated Ras signaling","volume":"6","author":"Joshi","year":"2013","journal-title":"Sci Signal"},{"issue":"12","key":"10.1016\/j.jpet.2026.104327_bib15","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1158\/0008-5472.CAN-12-3874","article-title":"Enhanced Effector Responses in Activated CD8+ T Cells Deficient in Diacylglycerol Kinases","volume":"73","author":"Riese","year":"2013","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.jpet.2026.104327_bib16","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ni958","article-title":"Enhanced T cell responses due to diacylglycerol kinase \u03b6 deficiency","volume":"4","author":"Zhong","year":"2003","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.jpet.2026.104327_bib17","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ni1400","article-title":"Disruption of diacylglycerol metabolism impairs the induction of T cell anergy","volume":"7","author":"Olenchock","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jpet.2026.104327_bib18","doi-asserted-by":"crossref","first-page":"1032113","DOI":"10.3389\/fimmu.2022.1032113","article-title":"Manipulation of diacylglycerol and ERK-mediated signaling differentially controls CD8+ T cell responses during chronic viral infection","volume":"13","author":"Harabuchi","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jpet.2026.104327_bib19","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/ijc.28837","article-title":"NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention","volume":"135","author":"Prinz","year":"2014","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.jpet.2026.104327_bib20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.4049\/jimmunol.1600581","article-title":"Diacylglycerol Kinase \u03b6 Is a Target To Enhance NK Cell Function","volume":"197","author":"Yang","year":"2016","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104327_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-04537-x","article-title":"DGKZ promotes TGF\u03b2 signaling pathway and metastasis in triple-negative breast cancer by suppressing lipid raft-dependent endocytosis of TGF\u03b2R2","volume":"13","author":"Zhao","year":"2022","journal-title":"Cell Death Dis"},{"issue":"20","key":"10.1016\/j.jpet.2026.104327_bib22","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.3390\/cancers13205190","article-title":"The Roles of Diacylglycerol Kinase \u03b1 in Cancer Cell Proliferation and Apoptosis","volume":"13","author":"Sakane","year":"2021","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.jpet.2026.104327_bib23","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1158\/0008-5472.CAN-18-0030","article-title":"CRISPR\/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells","volume":"78","author":"Jung","year":"2018","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.jpet.2026.104327_bib24","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1007\/s00262-021-02924-5","article-title":"Diacylglycerol kinase \u03b1 inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program","volume":"70","author":"Arranz-Nicol\u00e1s","year":"2021","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"7","key":"10.1016\/j.jpet.2026.104327_bib25","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1074\/jbc.M110.171884","article-title":"Decreased Diacylglycerol Metabolism Enhances ERK Activation and Augments CD8+ T Cell Functional Responses","volume":"286","author":"Riese","year":"2011","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jpet.2026.104327_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4049\/immunohorizons.1700055","article-title":"Diacylglycerol Kinase \u03b6 (DGK\u03b6) and Casitas b-Lineage Proto-Oncogene b\u2013Deficient Mice Have Similar Functional Outcomes in T Cells but DGK\u03b6-Deficient Mice Have Increased T Cell Activation and Tumor Clearance","volume":"2","author":"Wesley","year":"2018","journal-title":"Immunohorizons"},{"issue":"719","key":"10.1016\/j.jpet.2026.104327_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.adh1892","article-title":"DGK\u03b1\/\u03b6 inhibitors combine with PD-1 checkpoint therapy to promote T cell\u2013mediated antitumor immunity","volume":"15","author":"Wichroski","year":"2023","journal-title":"Sci Transl Med"},{"issue":"47","key":"10.1016\/j.jpet.2026.104327_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk1853","article-title":"DGK\u03b1\/\u03b6 inhibition lowers the TCR affinity threshold and potentiates antitumor immunity","volume":"9","author":"Kureshi","year":"2023","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.jpet.2026.104327_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/2326-6066.CIR-20-0216","article-title":"DGKA mediates resistance to PD-1 blockade","volume":"9","author":"Fu","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jpet.2026.104327_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2023.100999","article-title":"Diacylglycerol kinases: A look into the future of immunotherapy","volume":"91","author":"Martin-Salgado","year":"2024","journal-title":"Adv Biol Regul"},{"issue":"9","key":"10.1016\/j.jpet.2026.104327_bib31","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2326-6066.CIR-25-0156","article-title":"Discovery of BMS-986408, a First-In-Class Dual DGK\u03b1 and DGK\u03b6 Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies","volume":"13","author":"Wichroski","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jpet.2026.104327_bib32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fcell.2016.00140","article-title":"Diacylglycerol Kinases: Shaping Diacylglycerol and Phosphatidic Acid Gradients to Control Cell Polarity","volume":"4","author":"Baldanzi","year":"2016","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104327_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1941566","article-title":"DGK\u03b6 exerts greater control than DGK\u03b1 over CD8+ T cell activity and tumor inhibition","volume":"10","author":"Gu","year":"2021","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.jpet.2026.104327_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/icb.2017.7","article-title":"Predominant contribution of DGK\u03b6 over DGK\u03b1 in the control of PKC\/PDK-1-regulated functions in T cells","volume":"95","author":"\u00c1vila-Flores","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jpet.2026.104327_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ebiom.2017.04.024","article-title":"Diacylglycerol Kinase \u03b6 Limits Cytokine-dependent Expansion of CD8 + T Cells with Broad Antitumor Capacity","volume":"19","author":"Andrada","year":"2017","journal-title":"EBioMedicine"},{"issue":"1-2","key":"10.1016\/j.jpet.2026.104327_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000351849","article-title":"Evaluations of the selectivities of the diacylglycerol kinase inhibitors R59022 and R59949 among diacylglycerol kinase isozymes using a new non-radioactive assay method","volume":"92","author":"Sato","year":"2013","journal-title":"Pharmacology"},{"key":"10.1016\/j.jpet.2026.104327_bib37","series-title":"Diacylglycerol kinase modulating compounds","author":"Sawa","year":"2021"},{"key":"10.1016\/j.jpet.2026.104327_bib38","series-title":"Substituted aminothiazoles as dgkzeta inhibitors for immune activation","author":"Schmees","year":"2021"},{"issue":"10","key":"10.1016\/j.jpet.2026.104327_bib39","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1021\/cr1004106","article-title":"Regulation and functions of diacylglycerol kinases","volume":"111","author":"Shulga","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.jpet.2026.104327_bib40","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.3389\/fimmu.2019.03048","article-title":"DGK \u03b1 and \u03b6 Activities Control TH1 and TH17 Cell Differentiation","volume":"10","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104327_bib41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1021\/acsmedchemlett.3c00063","article-title":"Discovery of Potent, Dual-Inhibitors of Diacylglycerol Kinases Alpha and Zeta Guided by Phenotypic Optimization","volume":"14","author":"Chupak","year":"2023","journal-title":"ACS Med Chem Lett"},{"issue":"6","key":"10.1016\/j.jpet.2026.104327_bib42","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.4049\/jimmunol.180.6.3900","article-title":"A Role for CD8 in the Developmental Tuning of Antigen Recognition and CD3 Conformational Change","volume":"180","author":"Gil","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2026.104327_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104327_bib44","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.4049\/jimmunol.1102265","article-title":"Differential Regulation of Primary and Memory CD8 T Cell Immune Responses by Diacylglycerol Kinases","volume":"188","author":"Shin","year":"2012","journal-title":"J Immunol"},{"issue":"303","key":"10.1016\/j.jpet.2026.104327_bib45","doi-asserted-by":"crossref","first-page":"ra101","DOI":"10.1126\/scisignal.2004411","article-title":"Diacylglycerol Kinase \u03b6 Limits the Generation of Natural Regulatory T Cells","volume":"6","author":"Schmidt","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.jpet.2026.104327_bib46","article-title":"Optimal enhancement of anti-tumor T-cell immunity through the combined use of selective DGK zeta and DGK alpha inhibitors","volume":"12","author":"Offringa","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.jpet.2026.104327_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1423-0127-21-28","article-title":"Diacylglycerol kinase as a possible therapeutic target for neuronal diseases","volume":"21","author":"Shirai","year":"2014","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104327_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1083\/jcb.153.1.207","article-title":"Role of Diacylglycerol Kinase \u03b1 in the Attenuation of Receptor Signaling","volume":"153","author":"Sanju\u00e1n","year":"2001","journal-title":"J Cell Biol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104327_bib49","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.4049\/jimmunol.170.6.2877","article-title":"T Cell Activation In Vivo Targets Diacylglycerol Kinase \u03b1 to the Membrane: A Novel Mechanism for Ras Attenuation","volume":"170","author":"Sanju\u00e1n","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2026.104327_bib50","article-title":"Stereoselective degradation of diacylglycerol kinases potentiate T cell activation and tumor cell cytotoxicity","author":"Shaikh","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.jpet.2026.104327_bib51","doi-asserted-by":"crossref","first-page":"1297175","DOI":"10.3389\/fimmu.2023.1297175","article-title":"Small molecule inhibitors for cancer immunotherapy and associated biomarkers \u2013 the current status","volume":"14","author":"Schlicher","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.104327_bib52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1600-065X.2008.00647.x","article-title":"Diacylglycerol kinases in immune cell function and self-tolerance","volume":"224","author":"Zhong","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jpet.2026.104327_bib53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fcell.2016.00130","article-title":"Diacylglycerol Kinases in T Cell Tolerance and Effector Function","volume":"4","author":"Chen","year":"2016","journal-title":"Front Cell Dev Biol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526005264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526005264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:04:04Z","timestamp":1779955444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526005264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0022356526005264"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104327","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of both DGK\u03b1 and DGK\u03b6 is required for optimal T cell activation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104327"}}